From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
Olivier Mirguet
1
,
Yann Lamotte
2
,
Frédéric Donche
2
,
Jérôme Toum
2
,
Françoise Gellibert
2
,
Anne Bouillot
2
,
Romain Gosmini
2
,
Van Loc Nguyen
2
,
Delphine Delannée
2
,
Jonathan T Seal
2
,
Florence Blandel
2
,
Anne-Bénédicte Boullay
2
,
Eric Boursier
2
,
Sandrine Martin
2
,
Jean Marie Brusq
2
,
Gael Krysa
2
,
Alizon Riou
2
,
Rémi Tellier
2
,
Agnès Costaz
2
,
Pascal Huet
2
,
Yann Dudit
2
,
L Trottet
2
,
Jorge Kirilovsky
2
,
Edwige Nicodeme
2
1
Lipid Metabolism Discovery Performance Unit, GlaxoSmithKline, Les Ulis Cedex, France.
|
2
Lipid Metabolism Discovery Performance Unit, GlaxoSmithKline, 25 avenue du Québec, 91951 Les Ulis Cedex, France
|
Тип публикации: Journal Article
Дата публикации: 2012-04-01
scimago Q2
wos Q2
БС2
SJR: 0.472
CiteScore: 5.1
Impact factor: 2.2
ISSN: 0960894X, 14643405
PubMed ID:
22386529
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Краткое описание
The discovery, synthesis and biological evaluation of a novel series of 7-isoxazoloquinolines is described. Several analogs are shown to increase ApoA1 expression within the nanomolar range in the human hepatic cell line HepG2.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
2
4
6
8
10
12
14
16
18
|
|
|
Journal of Medicinal Chemistry
17 публикаций, 15.6%
|
|
|
MedChemComm
7 публикаций, 6.42%
|
|
|
European Journal of Medicinal Chemistry
4 публикации, 3.67%
|
|
|
Future Medicinal Chemistry
3 публикации, 2.75%
|
|
|
Bioorganic Chemistry
3 публикации, 2.75%
|
|
|
ChemMedChem
3 публикации, 2.75%
|
|
|
Nature Reviews Drug Discovery
2 публикации, 1.83%
|
|
|
Nature Communications
2 публикации, 1.83%
|
|
|
Bioorganic and Medicinal Chemistry Letters
2 публикации, 1.83%
|
|
|
ACS Medicinal Chemistry Letters
2 публикации, 1.83%
|
|
|
ACS Chemical Biology
2 публикации, 1.83%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
2 публикации, 1.83%
|
|
|
Letters in Drug Design and Discovery
1 публикация, 0.92%
|
|
|
Current Medicinal Chemistry
1 публикация, 0.92%
|
|
|
Epigenomics
1 публикация, 0.92%
|
|
|
Pharmaceutical patent analyst
1 публикация, 0.92%
|
|
|
Therapeutic Advances in Hematology
1 публикация, 0.92%
|
|
|
Cancers
1 публикация, 0.92%
|
|
|
International Journal of Molecular Sciences
1 публикация, 0.92%
|
|
|
Metabolites
1 публикация, 0.92%
|
|
|
Frontiers in Immunology
1 публикация, 0.92%
|
|
|
Cellular and Molecular Life Sciences
1 публикация, 0.92%
|
|
|
Epigenetics and Chromatin
1 публикация, 0.92%
|
|
|
Scientific Reports
1 публикация, 0.92%
|
|
|
Signal Transduction and Targeted Therapy
1 публикация, 0.92%
|
|
|
Atherosclerosis
1 публикация, 0.92%
|
|
|
Drug Discovery Today: Technologies
1 публикация, 0.92%
|
|
|
Current Opinion in Chemical Biology
1 публикация, 0.92%
|
|
|
Pharmacology and Therapeutics
1 публикация, 0.92%
|
|
|
2
4
6
8
10
12
14
16
18
|
Издатели
|
5
10
15
20
25
30
|
|
|
Elsevier
27 публикаций, 24.77%
|
|
|
American Chemical Society (ACS)
24 публикации, 22.02%
|
|
|
Springer Nature
12 публикаций, 11.01%
|
|
|
Wiley
10 публикаций, 9.17%
|
|
|
Royal Society of Chemistry (RSC)
9 публикаций, 8.26%
|
|
|
Taylor & Francis
7 публикаций, 6.42%
|
|
|
MDPI
3 публикации, 2.75%
|
|
|
Bentham Science Publishers Ltd.
2 публикации, 1.83%
|
|
|
SAGE
2 публикации, 1.83%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 публикации, 1.83%
|
|
|
Frontiers Media S.A.
1 публикация, 0.92%
|
|
|
American Association for Cancer Research (AACR)
1 публикация, 0.92%
|
|
|
American Society of Clinical Oncology (ASCO)
1 публикация, 0.92%
|
|
|
Cold Spring Harbor Laboratory
1 публикация, 0.92%
|
|
|
Portland Press
1 публикация, 0.92%
|
|
|
Georg Thieme Verlag KG
1 публикация, 0.92%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 0.92%
|
|
|
5
10
15
20
25
30
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
109
Всего цитирований:
109
Цитирований c 2025:
3
(2.75%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Mirguet O. et al. From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151 // Bioorganic and Medicinal Chemistry Letters. 2012. Vol. 22. No. 8. pp. 2963-2967.
ГОСТ со всеми авторами (до 50)
Скопировать
Mirguet O., Lamotte Y., Donche F., Toum J., Gellibert F., Bouillot A., Gosmini R., Nguyen V. L., Delannée D., Seal J. T., Blandel F., Boullay A., Boursier E., Martin S., Brusq J. M., Krysa G., Riou A., Tellier R., Costaz A., Huet P., Dudit Y., Trottet L., Kirilovsky J., Nicodeme E. From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151 // Bioorganic and Medicinal Chemistry Letters. 2012. Vol. 22. No. 8. pp. 2963-2967.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/j.bmcl.2012.01.125
UR - https://doi.org/10.1016/j.bmcl.2012.01.125
TI - From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
T2 - Bioorganic and Medicinal Chemistry Letters
AU - Mirguet, Olivier
AU - Lamotte, Yann
AU - Donche, Frédéric
AU - Toum, Jérôme
AU - Gellibert, Françoise
AU - Bouillot, Anne
AU - Gosmini, Romain
AU - Nguyen, Van Loc
AU - Delannée, Delphine
AU - Seal, Jonathan T
AU - Blandel, Florence
AU - Boullay, Anne-Bénédicte
AU - Boursier, Eric
AU - Martin, Sandrine
AU - Brusq, Jean Marie
AU - Krysa, Gael
AU - Riou, Alizon
AU - Tellier, Rémi
AU - Costaz, Agnès
AU - Huet, Pascal
AU - Dudit, Yann
AU - Trottet, L
AU - Kirilovsky, Jorge
AU - Nicodeme, Edwige
PY - 2012
DA - 2012/04/01
PB - Elsevier
SP - 2963-2967
IS - 8
VL - 22
PMID - 22386529
SN - 0960-894X
SN - 1464-3405
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2012_Mirguet,
author = {Olivier Mirguet and Yann Lamotte and Frédéric Donche and Jérôme Toum and Françoise Gellibert and Anne Bouillot and Romain Gosmini and Van Loc Nguyen and Delphine Delannée and Jonathan T Seal and Florence Blandel and Anne-Bénédicte Boullay and Eric Boursier and Sandrine Martin and Jean Marie Brusq and Gael Krysa and Alizon Riou and Rémi Tellier and Agnès Costaz and Pascal Huet and Yann Dudit and L Trottet and Jorge Kirilovsky and Edwige Nicodeme},
title = {From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2012},
volume = {22},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/j.bmcl.2012.01.125},
number = {8},
pages = {2963--2967},
doi = {10.1016/j.bmcl.2012.01.125}
}
Цитировать
MLA
Скопировать
Mirguet, Olivier, et al. “From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151.” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 8, Apr. 2012, pp. 2963-2967. https://doi.org/10.1016/j.bmcl.2012.01.125.